ArticlePloS one2022
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
Erratum issuedAbstract read
In one paragraph
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Clinical trial laboratory principles for emerging infectious disease research in resource-limited settings.Trends open · 2026Article
- COVID-19 vaccine immunogenicity in Mongolian adults with and without chronic hepatitis.BMC infectious diseases · 2026Article
- SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024Article
- Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).PloS one · 2024Article
- International clinical research networks - a collaborative approach for pandemic preparedness and response: The case of The Mexican Emerging Infectious Disease Clinical Research Network (LaRed).Journal of global health · 2023Article
- Challenges of conducting an international observational study to assess immunogenicity of multiple COVID-19 vaccines.PLOS global public health · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
54 authors.
Irini SeretiDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Kathryn Shaw-SalibaDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Lori E DoddDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Robin L DewarVirus Isolation and Serology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Sylvain LaverdureLaboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Shawn BrownAIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Olivier Tshiani MbayaClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Jean Jacques Muyembe TamfumInstitut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
Placide Mblala-KingebeniInstitut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
Ydrissa SowDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Esther AkpaDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Mory Cherif HaidaraCentre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
Karine Fouth TchosDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Abdoul Habib BeavoguiCentre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
Aaron NealDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Dona ArlindaMinistry of Health, Jakarta, Indonesia.
Dewi LokidaIndonesia Research Partnership on Infectious Diseases National Institute of Health Research and Development, Jakarta, Indonesia.
Louis GrueClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Mary SmolskisDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Laura A McNayDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Dehkontee Gayedyu-DennisPartnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia.
Guillermo M Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
Abelardo Montenegro-LiendoThe Mexican Emerging Infectious Diseases Clinical Research Network, Ciudad de México, Mexico.
Moctar TounkaraUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Seydou SamakeUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Ganbolor JargalsaikhanThe Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
Delgersaikhan ZulkhuuThe Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
Shera WeyersClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Tyler BonnettClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Gail E PotterDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Randy StevensAIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Adam RupertAIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Jamila AboulhabDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Jean-Luc BiampataInstitut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
Alexandre DelamoCentre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
Bienvenu Salim CamaraCentre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
Herman Kosasih IndonesiaIndonesia Research Partnership on Infectious Diseases National Institute of Health Research and Development, Jakarta, Indonesia.
Muhammad KaryanaMinistry of Health, Jakarta, Indonesia.
James T DuworkoPartnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia.
Justino Regalado-PinedaSubdirección de Medicina, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, Mexico.
Paola Del Carmen Guerra-de-BlasThe Mexican Emerging Infectious Diseases Clinical Research Network, Ciudad de México, Mexico.
Seydou DoumbiaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Djeneba DabitaoUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Naranjargal DashdorjThe Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
Naranbaatar DashdorjThe Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
Kevin NewellClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Alyson FrancisSystex, Inc, Rockville, Maryland, United States of America.
Kevin RubensteinClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.ORCID 0000-0003-3516-5932
Victoria BeraSystex, Inc, Rockville, Maryland, United States of America.
Iman GulatiSystex, Inc, Rockville, Maryland, United States of America.
Ratna SardanaDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Monica MillardClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Renee RidzonDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0002-2822-8897
Sally HunsbergerDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Funding
WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6MWest African Center of Excellence for Global Health Bioinformatics Research TrainingU2RTW010673 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DOUMBIA, SEYDOU, LI, JIAN · 2017 to 2021
$1.2MMali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP)D43TW011818 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI SEYDOU DOUMBIA · 2022 to 2026
$1.2MFIC NIH HHS D43 TW011818NCI NIH HHS 75N91019D00024
Abstract
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.
Indexed as
COVID-19VaccinesCohort StudiesCOVID-19 VaccinesHumansPandemicsCOVID-19 VaccinesVaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC0
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.